DONATE TODAY
To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

October 2, 2023

Have YOUR Voice Heard! EBCI Is Raising Patient Voices

EBCI logo white
Megaphone image

Make YOUR Voice Heard

The End Brain Cancer Initiative (EBCI) is raising patient voices! Participating in one of the studies below will help advance our understanding of the treatment and management of these diseases. 

Recurrent Glioblastoma (rGBM) Study

rGBM study poster
Shreya Prakash photo

Now offering evening availability!
To better accommodate working participants and those in different time zones, our Clinical Research Coordinator/Patient Navigator is now available two evenings a week to conduct rGBM Study interviews: Tuesdays and Wednesdays from 6PM to 9PM PST.

Questions? Contact Shreya Prakash: 
425-436-8688 | shreya@endbraincancer.org

Low Grade Glioma (LGG) Patient Survey

Servier Pharmaceuticals is striving to better understand the treatment experience of Low Grade Glioma (LGG) patients with a short online survey. Responses from this anonymous survey will be used to build programs to better serve Low Grade Glioma patients and their families.

  • 15-minute online survey
  • For LGG patients and their caregivers
  • Patients must be 18+ years old

Metastatic Non-Small Cell Lung Cancer (NSCLC) Survey

People diagnosed within the last three years with Non-Small Cell Lung Cancer (NSCLC) that has metastasized to the brain are invited to participate in this paid opportunity to help advance our understanding of the treatment and management of this cancer.

  • 10-15 minute surveys for up to 2 weeks
  • 60 minutes total of tasks
  • Receive $200 for your time
survey

Metastatic Non-Small Cell Lung Cancer (NSCLC) Survey

National Caregivers Online Event
November 3rd, 2023
11:00am - 1:00pm PST

Caregiver logo with Novocure sponsor

Sponsor logos

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram